Is IQV or UTHR cheaper?

On trailing earnings, UTHR is cheaper: IQV trades at a 22.49 P/E and UTHR at 20.18.

Which has grown faster, IQV or UTHR?

Over the past five years, UTHR grew revenue faster — IQV at a 6.72% CAGR versus UTHR at 16.05%.

Is IQV or UTHR more profitable?

UTHR runs the higher net margin — IQV at 8.33% versus UTHR at 40.61%.

Which has been the better investment, IQV or UTHR?

Over the past 10-year, UTHR delivered the higher annualized total return — IQV at 10.71% versus UTHR at 17.22%. Past performance doesn't predict future results.

IQVIA Holdings Inc. (IQV) vs United Therapeutics Corporation (UTHR)

UTHR leads on 10 of 15 compared metrics.

A side-by-side comparison of IQVIA Holdings Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

United Therapeutics Corporation

$23.17B

$545.96Healthcare

Total return — IQV vs UTHR

growth of $100 · last 13y

IQV +330.9%UTHR +734.8%UTHR compounded faster

IQV UTHR

IQV vs UTHR: by the numbers

•IQV is the larger company ($30.29B vs $23.17B market cap).
•UTHR trades at the lower earnings multiple (20.18 vs 22.49 P/E).
•UTHR converts more revenue to profit (40.61% vs 8.33% net margin).
•UTHR grew revenue faster over the past five years (16.05% vs 6.72% CAGR).

Which is better, IQV or UTHR?

Metric tally: IQV 5 · UTHR 10

It depends on what you're optimizing for:

ValueUTHR(lower P/E)

GrowthUTHR(faster 5Y revenue CAGR)

QualityUTHR(higher ROIC)

Metrics side by side

Valuation

Metric	IQV	UTHR
P/E ratio	22.49	20.18●
Forward P/E	12.81●	16.48
P/S ratio	1.85●	8.13
P/B ratio	4.95	4.37●
PEG ratio	6.34	1.16●
EV / EBITDA	12.77●	14.41
FCF yield	8.26%●	3.95%

Profitability

Metric	IQV	UTHR
Gross margin	26.11%	86.58%●
Operating margin	13.86%	45.34%●
Net margin	8.33%	40.61%●
ROE	22.26%	21.82%
ROIC	8.23%	16.14%●

Growth (annualized)

Metric	IQV	UTHR
Revenue CAGR (5Y)	6.72%	16.05%●
EPS CAGR (5Y)	40.21%●	20.93%
FCF CAGR (5Y)	4.53%	12.12%●
Total return CAGR (5Y)	-5.71%	24.96%●

Frequently asked

Which is better, IQV or UTHR?: It depends on your goal. value: UTHR (lower P/E); growth: UTHR (faster 5Y revenue CAGR); quality: UTHR (higher ROIC). Across all compared metrics, UTHR leads 10 to 5.
Is IQV or UTHR cheaper?: On trailing earnings, UTHR is cheaper: IQV trades at a 22.49 P/E and UTHR at 20.18.
Which has grown faster, IQV or UTHR?: Over the past five years, UTHR grew revenue faster — IQV at a 6.72% CAGR versus UTHR at 16.05%.
Is IQV or UTHR more profitable?: UTHR runs the higher net margin — IQV at 8.33% versus UTHR at 40.61%.
Which has been the better investment, IQV or UTHR?: Over the past 10-year, UTHR delivered the higher annualized total return — IQV at 10.71% versus UTHR at 17.22%. Past performance doesn't predict future results.

Go deeper

Full IQV analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

IQVIA P/E ratio United Therapeutics P/E ratio IQVIA dividend yield United Therapeutics dividend yield IQVIA ROE United Therapeutics ROE IQVIA operating margin United Therapeutics operating margin IQVIA revenue growth United Therapeutics revenue growth IQVIA free cash flow United Therapeutics free cash flow

IQVIA & United Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.